Polpharma Pharmaceutical Works - API Manufacturer

 

Strategy and goals

 

Polpharma Fine Chemicals Business Unit is building its position as an active supplier of generic APIs on the global market. The company strives to become a leading player in this market segment.

 

Vertical integration with the Pharma Business Unit gives us advantage in the area of quality and cost. At the same time we prove flexibility of the services provided.

 

Our goal is to manage innovation with good practices, understand customers’ needs and provide the best solutions for them.

 

 

Innovation and technology

 

Continuous innovation is the way to convert human capital and invested resources into value for our company. Polpharma encourages new ideas and transforms them into innovative applications to enhance our competitiveness.

 

In an ever changing world of technological advances and increasing environmental concerns Polpharma puts through innovative ideas and versatile solutions.

 

 

World class service

 

Our goal is to understand the needs of our customers and provide optimum solutions.

 

We constantly seek ways to adding value to everything we do for our customers. We make sure to keep our API portfolio updated and expand it with new, attractive compounds.

 

Quality, optimization and customer satisfaction are the driving forces behind our work.

 

Expertise and experience

 

Highly skilled and well motivated staff is Polpharma's greatest asset.

 

To complement in-house expertise we have developed a collaborative relationship with partnering laboratories and institutes.

 

A key to the success is a combination of in-house expertise and effective co-operation with scientific institutions.

Latest news

Successful GMP audit by Japanese companies

Thursday, 01-07-2010
Polpharma Fine Chemicals Business Unit passed successfully inspection by two of the major generic Japanese...

About us

Polpharma Pharmaceutical Works is a world-class manufacturer, and the largest producer of Active Pharmaceutical Ingredients (API) in Poland.

read more

 

Sustainable development

Our strategic imperative is the sustainable economic growth with environmental sustainability and sustainable working practices.

read more

 

Successful FDA inspection

Product safety is our top priority. The last FDA inspection in February 2009 concluded with no Inspectional Observations Form - 483.

 

read more

 

Copyright © 2009 Polpharma S.A. All rights reserved.
Realizacja: Ideo Powered by : EditoCMS